A Comparative Study of Drug-Eluting Stents and Bare-Metal Stents in Coronary Artery Disease

Syed Ahsan Akhtar; Farhat Ullah Khan; Zeeshan Afzal; Muhammad Hafeez; Muzdalfa Parvez

doi:10.70749/ijbr.v3i5.1211

Authors

Syed Ahsan Akhtar Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Farhat Ullah Khan Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Zeeshan Afzal Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Muhammad Hafeez Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan
Muzdalfa Parvez Department of Cardiology, Hayatabad Medical Complex, Peshawar, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i5.1211

Keywords:

Coronary Artery Disease, Drug-Eluting Stents, Bare-Metal Stents, Percutaneous Coronary Intervention, Restenosis, Target Lesion Revascularization

Abstract

Introduction: Coronary artery disease (CAD) holds the position as a top health issue that causes sickness and death throughout the global community. PCI represents a fundamental treatment approach, but the selection between DES and BMS medication delivery systems determines patient results. Objective: The research studied the medical success rates and safety characteristics between drug-eluting and bare-metal stents when used in PCI procedures for coronary artery disease. Materials and Method: Between January 2021 and June 2021, prospective comparative research was done at Department of Cardiology, Hayatabad Medical Complex, Peshawar. Two hundred patients joined the research into which they received either DES or BMS treatment (DES included 100 patients, and BMS included 100 patients). The study measured baseline patient data in addition to procedural success rates together with six-month clinical results. Results: Patients with DES experienced better outcomes than BMS patients because their restenosis rate was 6% lower and target lesion revascularization rate was 11% lower. The study results showed no statistically significant differences in mortality and myocardial infarction rates between groups. Conclusion: The clinical outcomes of DES prove better than those of BMSs, and medical authorities regard them as the go-to stenting solution for most PCI procedures.

Downloads

Download data is not yet available.

References

Jing, S., Jia, B., An, K., Li, N., Guo, H., Li, X., Wang, J. and Liu, W., Comparative Efficacy of Drug-Eluting Stents vs. Bare-Metal Stents in Symptomatic Vertebral Artery Stenosis: A Prospective Single-Center Study. Bare-Metal Stents in Symptomatic Vertebral Artery Stenosis: A Prospective Single-Center Study.

https://doi.org/10.2139/ssrn.5110389

Changal, K., Meenakshisundaram, C., Zafarullah, F.N.U., Nazir, S. and Sheikh, M.A., 2021. Meta-analysis and critical review of observational studies comparing drug-eluting and bare metal stents for revascularization of large coronary arteries. Cardiovasc Revasc Med, 31, pp.91-92.

https://doi.org/10.1016/j.carrev.2020.11.003

Park, H., Ahn, J.M., Kang, D.Y., Kim, S.O., Ko, E., Kim, T.O., Lee, P.H., Lee, S.W., Park, S.W., Park, D.W. and Park, S.J., 2021. Very long-term safety and effectiveness of drug-eluting or bare-metal stents for left main coronary disease. CJC open, 3(10), pp.1199-1206.

https://doi.org/10.1016/j.cjco.2021.05.009

Zhang, Y., Li, W. and Zhang, L., 2024. Efficacy and safety of drug-eluting stents versus bare-metal stents in symptomatic intracranial and vertebral artery stenosis: a meta-analysis. Frontiers in Neurology, 15, p.1389254.

https://doi.org/10.3389/fneur.2024.1389254

Chunawala, Z., Goyal, A., Jaiswal, V., Moussa, I., Hassan, A., Bhatia, K. and Qamar, A., 2023. Comparison of Drug-Eluting Stent With Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis. Circulation, 148(Suppl_1), pp.A19047-A19047.

https://doi.org/10.1161/circ.148.suppl_1.19047

Gouëffic, Y., Torsello, G., Zeller, T., Esposito, G., Vermassen, F., Hausegger, K.A., Tepe, G., Thieme, M., Gschwandtner, M., Kahlberg, A. and Schindewolf, M., 2022. Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial. Circulation, 146(21), pp.1564-1576.

https://doi.org/10.1161/circulationaha.122.059606

Siddiqui, M.U., Warner, E., Junarta, J., O’Neill, P., Signarovitz, D., Kanawati, E., Murtaza, M. and Fischman, D., 2024. Outcomes of Drug‐Eluting Stents in comparison to Bare Metal Stents in Cancer Patients with Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis. Journal of Interventional Cardiology, 2024(1), p.3072909.

https://doi.org/10.1155/2024/3072909

Piccolo, R., Bonaa, K.H., Efthimiou, O., Varenne, O., Baldo, A., Urban, P., Kaiser, C., de Belder, A., Lemos, P.A., Wilsgaard, T. and Reifart, J., 2022. Individual patient data meta-analysis of drug-eluting versus bare-metal stents for percutaneous coronary intervention in chronic versus acute coronary syndromes. The American Journal of Cardiology, 182, pp.8-16.

https://doi.org/10.1016/j.amjcard.2022.07.035

Rahman, M., Hanif, M., Mumtaz, M., Nair, A., Ali, J., Khan, B., Ullah, W. and Savage, M.P., 2023. Comparative Efficacy and Safety of Bare-Metal versus Drug-Eluting Stents in Managing Saphenous Venous Graft Disease: A Meta-Analysis and Systematic Review. Circulation, 148(Suppl_1), pp.A13590-A13590.

https://doi.org/10.1161/circ.148.suppl_1.13590

Piccolo, R., Bonaa, K.H., Efthimiou, O., Varenne, O., Urban, P., Kaiser, C., Raeber, L., de Belder, A., Remkes, W., Van’T Hof, A.W. and Stankovic, G., 2021. Drug‐Eluting or Bare‐Metal Stents for Left Anterior Descending or Left Main Coronary Artery Revascularization. Journal of the American Heart Association, 10(20), p.e018828.

https://doi.org/10.1161/jaha.120.018828

Gong, H., Luo, J., Xu, W., Wang, J., Yang, R., Yang, B., Ma, Y., Wang, T. and Jiao, L., 2024. Drug-eluting stents versus bare-metal stents for intracranial atherosclerotic stenosis: a systematic review and meta-analysis. BMJ open, 14(12), p.e085533.

https://doi.org/10.1136/bmjopen-2024-085533

Murai, K. and Noguchi, T., 2023. Exploring alternatives to drug-eluting stents: the potential of combining drug coated balloon with bare-metal stents. Cardiovascular Diagnosis and Therapy, 13(5), p.768.

https://doi.org/10.21037/cdt-23-297

Walse, R.S., Nair, K.K.M., Valaparambil, A., Sasidharan, B., Sivadasapillai, H. and Thulaseedharan, J.V., 2023. Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents. Indian Heart Journal, 75(6), pp.457-461.

https://doi.org/10.1016/j.ihj.2023.11.001

Ray, S., 2021. The Relevance of Bare-Metal Stent in the Therapy of Coronary Artery Disease in 2020. Journal of Indian College of Cardiology, 11(1), pp.1-4.

https://doi.org/10.4103/jicc.jicc_30_20

Si, J.H., Ma, N., Gao, F., Mo, D.P., Luo, G. and Miao, Z.R., 2022. Effect of a drug-eluting stent vs. bare metal stent for the treatment of symptomatic intracranial and vertebral artery stenosis. Frontiers in Neurology, 13, p.854226.

https://doi.org/10.3389/fneur.2022.854226